What is the appropriate management plan for a patient with hyperdynamic left‑ventricular wall motion, a mild left‑ventricular outflow tract (LVOT) gradient, and moderate aortic stenosis, moderate aortic regurgitation, and moderate mitral regurgitation?

Management of Multivalvular Disease with Hyperdynamic LV and Mild LVOT Gradient

This patient requires comprehensive multidisciplinary Heart Team evaluation with strong consideration for dual valve surgery addressing both the aortic and mitral pathology, as the combination of moderate aortic stenosis, moderate aortic regurgitation, and moderate mitral regurgitation creates cumulative hemodynamic burden that may warrant intervention earlier than isolated moderate lesions would typically require 1, 2.

Initial Diagnostic Approach

The hyperdynamic wall motion with mild LVOT gradient suggests either:

• Hyperdynamic state from volume overload (from the regurgitant lesions)
• Underlying hypertrophic physiology contributing to dynamic obstruction
• High-flow state across stenotic valve creating gradient amplification

Critical diagnostic steps:

• Perform comprehensive transthoracic echocardiography to quantify each lesion independently, then assess their combined hemodynamic impact 1
• Measure LV dimensions (LVESD, LVEDD) and ejection fraction to detect early dysfunction
• Assess for systolic anterior motion (SAM) of mitral valve that could explain LVOT gradient 3, 4
• Consider transesophageal echocardiography if TTE windows inadequate or to better characterize mitral valve anatomy 1
• Exercise hemodynamic testing if symptoms seem disproportionate to resting findings, as mixed valve disease patients may develop elevated gradients with increased flow 5

Understanding the Pathophysiology

The combination creates a "perfect storm" scenario 6:

• Aortic stenosis + regurgitation: Increases afterload from both reduced valve area AND regurgitant volume returning to LV 5
• Adding mitral regurgitation: Elevates left atrial pressure and creates volume overload
• Hyperdynamic state: May represent compensatory response but risks worsening LVOT obstruction if any hypertrophic component exists

Critical pitfall: Mixed moderate valve disease can produce symptoms and chamber remodeling earlier than isolated severe lesions because the hemodynamic insults are additive 5.

Determining Predominant Lesion

Identify which valve pathology is driving symptoms 2, 1:

If aortic stenosis predominant:

• Peak velocity ≥4.0 m/s or mean gradient ≥40 mmHg with symptoms → AVR indicated 1
• Coexistent moderate AR does NOT preclude TAVI if otherwise suitable 5
• Address mitral regurgitation if moderate-to-severe during same operation 2, 7

If aortic regurgitation predominant:

• Symptomatic severe AR → AVR regardless of LV function 8
• Asymptomatic with LVEF <50% or LVESD >50mm → AVR indicated 8
• If moderate MR present during cardiac surgery, concomitant mitral intervention reasonable 2

If mitral regurgitation predominant:

• Determine if primary (organic) vs secondary (functional) 9
• Primary MR: Surgery if symptomatic with LVEF >30%, or asymptomatic with LVESD ≥45mm or LVEF ≤60% 10
• Secondary MR: Surgery indicated if undergoing CABG/other valve surgery with LVEF >30% 10

Surgical Decision Algorithm

For low-to-intermediate surgical risk patients:

1. If any valve is severe AND symptomatic → Dual valve surgery addressing both aortic and mitral pathology 1, 6

2. If moderate lesions but symptomatic with objective evidence (elevated BNP, elevated filling pressures on catheterization, severely reduced exercise capacity) → Consider dual valve surgery as cumulative burden may justify intervention 5

3. Mitral valve repair strongly preferred over replacement when feasible, especially for posterior leaflet pathology 9, 10

4. During aortic valve surgery, concomitant mitral intervention reasonable for moderate MR 2, 7

For high/prohibitive surgical risk patients:

Consider staged transcatheter approach 1:

• TAVI first (if AS predominant and moderate AR acceptable)
• Followed by mitral TEER if MR persists and anatomy suitable
• Note: Primary MR less likely to improve after AVR alone compared to secondary MR 1

Addressing the LVOT Gradient

If gradient related to hyperdynamic state from volume overload:

• Will likely resolve after valve surgery reduces regurgitant burden 11

If true dynamic obstruction (SAM, hypertrophic physiology):

• Avoid inotropes and vasodilators that worsen obstruction 11
• Beta-blockers or calcium channel blockers may help 12
• If severe LVOT obstruction coexists with valve disease, may require septal myectomy during valve surgery 4, 13

Surveillance Strategy

Until intervention:

• Moderate MR: Follow every 1-2 years with TTE 2
• Moderate AS/AR: Annual to biannual depending on symptoms and LV parameters 8
• More frequent monitoring warranted given multivalve disease - consider every 6-12 months 2
• Serial assessment of LV size and function critical, as dysfunction may develop earlier than with isolated lesions 5, 6

Key Clinical Caveats

• Do not delay surgery waiting for "severe" thresholds - combined moderate disease may warrant earlier intervention due to cumulative hemodynamic burden 5, 6
• LV dysfunction is common at presentation and worsens postoperatively in combined AR/MR, suggesting intervention should not be delayed 6
• Heart Team discussion mandatory - complexity requires cardiology, cardiac surgery, imaging specialists, and consideration of transcatheter options 2, 1, 14
• Beware "suicide left ventricle" - if severe AS coexists with dynamic LVOTO, AVR alone can precipitate catastrophic hemodynamic collapse; requires careful perioperative management 13